Peracetic Acid Molecules

AGA Nanotech is safeguarding tomorrow by innovating against antimicrobial resistance today

Why AMR Matters & The Clinical Need

Antimicrobial resistance (AMR) is a global health crisis. The overuse and misuse of antibiotics have led to the emergence of drug-resistant bacteria, making infections harder to treat and increasing the risk of disease spread, severe illness, and death. AMR threatens the very foundations of modern medicine, jeopardizing the safety of surgeries, cancer treatments, and organ transplants. The clinical need to address AMR is urgent and critical. Explore how we are tackling this challenge and the importance of innovative solutions in safeguarding human health.

Learn More

Introducing Battlestar: Our Revolutionary Technology

Battlestar is our patented first-in-class antimicrobial delivery system that safely and stably releases oxidative biocides—peracetic acid and hydrogen peroxide—directly at the site of infection.

Learn More

Meet the AGA Nanotech Team

Our team is composed of passionate scientists, researchers, and industry experts dedicated to combating AMR. With a wealth of experience and a shared vision for a healthier future, we are committed to driving innovation and delivering impactful solutions. Get to know the people behind AGA Nanotech.

Our Team
Meet the AGA Nanotech Team

Partners in Innovation

Collaboration is key to our success. We work with leading research institutions, healthcare providers, and industry partners to advance our technology to bring our solutions to those who need them most. Learn more about our partners and how we are working together to fight AMR.

Our Publications
Our Technology Has Applications Across Healthcare Get In Touch

Latest News

AGA Nanotech Joins HTCC Accelerator Programme

AGA Nanotech is excited to announce our selection for the Healthcare Technologies Capabilities Connector (HTCC) SME Accelerator Programme

AGA Nanotech Awarded Best Pitch at SBC Catalyser Programme 2024

AGA Nanotech has been awarded the SBC Catalyser 2024 Award for Battlestars application in wound care. This recognition highlights our commitment to advancing infection prevention technologies.

AGA Nanotech Chosen for Prestigious Innovate UK Microbials Accelerator

AGA Nanotech is proud to announce its selection for the highly competitive Innovate UK Microbials Accelerator Programme.

Keep up with the latest developments at AGA Nanotech in our News section. Find updates on our latest developments, research partnerships and important company milestones. Our News